Dupont Capital Management’s AEON Biopharma AEON Stock Holding History

Dupont Capital Management’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$122	Hold	170	–	–	0.01%	30
2026 Q1	$167	Hold	170	–	–	﹤0.01%	90
2025 Q4	$187	Hold	170	–	–	﹤0.01%	92
2025 Q3	$137	Hold	170	–	–	﹤0.01%	96
2025 Q2	$129	Hold	170	–	–	﹤0.01%	96
2025 Q1	$99	Sell	170 -1	-0.6%	-$7	﹤0.01%	97
2024 Q4	$6.63K	Hold	171	–	–	﹤0.01%	73
2024 Q3	$12.9K	Hold	171	–	–	﹤0.01%	68
2024 Q2	$12.9K	Buy	+171	New	+$40.8K	﹤0.01%	65
2024 Q1	–	Hold	0	–	–	–	139
2023 Q4	–	Hold	0	–	–	–	142
2023 Q3	–	Hold	0	–	–	–	217
2023 Q1	–	Sell	-2,083	Closed	-$1.51M	–	755
2022 Q4	$1.51M	Hold	2,083	–	–	0.07%	225
2022 Q3	$1.48M	Hold	2,083	–	–	0.09%	248
2022 Q2	$1.47M	Hold	2,083	–	–	0.07%	305
2022 Q1	$1.47M	Hold	2,083	–	–	0.06%	342
2021 Q4	$1.46M	Hold	2,083	–	–	0.05%	383
2021 Q3	$1.46M	Hold	2,083	–	–	0.05%	409
2021 Q2	$1.44M	Buy	+2,083	New	+$1.46M	0.03%	466

Other funds holding AEON

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Dupont Capital Management's AEON Position: Q2 2026 in Review

Dupont Capital Management held its AEON Biopharma (AEON) position steady in Q2 2026 at 170 shares worth $122. The position accounts for 0.01% of the portfolio, ranked #30.

Dupont Capital Management first reported a position in AEON in Q2 2021 and has held it in 16 quarters since. The position peaked at $1.51M in Q4 2022. 22 funds tracked by Wall St. Rank hold AEON as of Q2 2026.

Dupont Capital Management held 170 shares of AEON Biopharma worth $122 as of Q2 2026.
Dupont Capital Management left its AEON Biopharma share count unchanged in Q2 2026.
AEON Biopharma made up 0.01% of Dupont Capital Management's portfolio in Q2 2026, its #30 holding.
Dupont Capital Management first reported a position in AEON Biopharma in Q2 2021 and has held it in 16 quarters since.
Dupont Capital Management's AEON Biopharma position peaked at $1.51M in Q4 2022.
22 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2026.

Based on Dupont Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.